NASDAQ: EWTX
Edgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?

Insider buying vs selling

Have Edgewise Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joanne M. DonovanCMO2026-04-0128,662$7.08
$202.93kBuy
Joanne M. DonovanCMO2026-04-0128,662$32.31
$926.10kSell
Joanne M. DonovanCMO2026-03-3121,338$7.08
$151.07kBuy
Joanne M. DonovanCMO2026-03-3121,338$32.12
$685.31kSell
Joanne M. DonovanCMO2026-03-276,735$30.98
$208.64kSell
Joanne M. DonovanCMO2026-03-279,623$30.98
$298.10kSell
Badreddin EdrisDirector2026-01-2110,463$1.93
$20.19kBuy
Badreddin EdrisDirector2026-01-2166,477$1.93
$128.30kBuy
Badreddin EdrisDirector2026-01-217,605$0.71
$5.40kBuy
Badreddin EdrisDirector2026-01-2117,236$29.44
$507.43kSell

1 of 3

EWTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EWTX insiders and whales buy or sell their stock.

EWTX Shareholders

What type of owners hold Edgewise Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC14.47%15,518,492$480.45MInstitution
Ra Capital Management LP9.72%10,428,437$322.86MInstitution
Blackrock Inc6.18%6,630,576$205.28MInstitution
Baker Bros Advisors LP6.13%6,575,940$203.59MInstitution
Paradigm Biocapital Advisors LP6.10%6,541,210$202.52MInstitution
Holdings A. Novo5.66%6,071,703$187.98MInsider
Novo Holdings A4.99%5,350,000$165.64MInstitution
Braidwell LP4.86%5,210,831$161.33MInstitution
Vanguard Group Inc4.54%4,871,624$150.83MInstitution
Janus Henderson Group PLC4.26%4,566,850$141.39MInstitution

1 of 3

EWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EWTX88.61%11.39%Net SellingNet Selling
NAMS74.47%25.53%Net SellingNet Selling
RCUS68.34%31.66%Net Selling
LQDA50.08%49.92%Net SellingNet Selling
ALMS62.16%23.09%Net Buying

Edgewise Therapeutics Stock Ownership FAQ

Who owns Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ: EWTX) is owned by 113.56% institutional shareholders, 14.60% Edgewise Therapeutics insiders, and 0.00% retail investors. Holdings A. Novo is the largest individual Edgewise Therapeutics shareholder, owning 6.07M shares representing 5.66% of the company. Holdings A. Novo's Edgewise Therapeutics shares are currently valued at $185.85M.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.